Virbagen canis SHAPPi/LT, Lyophilisat und Suspension zur Herstellung einer Injektionssuspension für Hunde
Virbagen canis SHAPPi/LT, Lyophilisat und Suspension zur Herstellung einer Injektionssuspension für Hunde
Authorised
- Canine distemper virus, strain Lederle VR128, Live
- Canine adenovirus 2, strain Manhattan, Live
- Canine parvovirus, strain Cornell 780916, Live
- Canine parainfluenza virus, strain Manhattan, Live
- Leptospira interrogans, serogroup Canicola, serovar Canicola, strain Virbac CBS, Inactivated
- Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain Virbac IS3, Inactivated
- Rabies virus, strain VP12, Inactivated
Product identification
Medicine name:
Virbagen canis SHAPPi/LT, Lyophilisat und Suspension zur Herstellung einer Injektionssuspension für Hunde
Active substance:
- Canine distemper virus, strain Lederle VR128, Live
- Canine adenovirus 2, strain Manhattan, Live
- Canine parvovirus, strain Cornell 780916, Live
- Canine parainfluenza virus, strain Manhattan, Live
- Leptospira interrogans, serogroup Canicola, serovar Canicola, strain Virbac CBS, Inactivated
- Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain Virbac IS3, Inactivated
- Rabies virus, strain VP12, Inactivated
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Canine distemper virus, strain Lederle VR128, Live5.00log10 tissue culture infective dose 501.00millilitre(s)
-
Canine adenovirus 2, strain Manhattan, Live6.00log10 tissue culture infective dose 501.00millilitre(s)
-
Canine parvovirus, strain Cornell 780916, Live7.00log10 tissue culture infective dose 501.00millilitre(s)
-
Canine parainfluenza virus, strain Manhattan, Live7.00log10 tissue culture infective dose 501.00millilitre(s)
-
Leptospira interrogans, serogroup Canicola, serovar Canicola, strain Virbac CBS, Inactivated833.00million organisms1.00millilitre(s)
-
Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain Virbac IS3, Inactivated833.00million organisms1.00millilitre(s)
-
Rabies virus, strain VP12, Inactivated1.00international unit(s)1.00millilitre(s)
Pharmaceutical form:
-
Lyophilisate and suspension for suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AJ06
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Austria
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
- Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
- Virbac
Responsible authority:
- Austrian Agency For Health And Food Safety
Authorisation number:
- 8-20138
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 12/06/2024
Updated on: 3/12/2024
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 12/06/2024
Updated on: 3/12/2024
Labelling
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 12/06/2024
Updated on: 3/12/2024
How useful was this page?: